
United Kingdom · Medical devices startup
GlySure Ltd is a UK-based medical technology company specializing in continuous glucose monitoring systems for hospital use, particularly in intensive care units.
Funding reportedLast round: Series C
Follow GlySure Ltd and see its new rounds in your feed.Start following
GlySure Ltd is a UK-based medical technology company specializing in continuous glucose monitoring systems for hospital use, particularly in intensive care units.
Founded in 2006 and headquartered in Abingdon, Oxfordshire, the company focuses on developing innovative solutions to support tight glycemic control in critically ill patients. The core product is a continuous intravascular glucose monitoring system that utilizes a proprietary optical fluorescence sensor. This system allows ICU clinicians to safely implement intensive insulin therapy by providing real-time blood glucose readings throughout a patient's stay in the ICU. GlySure's technology is designed to enhance patient care in hospital settings, specifically targeting the needs of ICU clinicians.
Funding, as reported
What they build
Known for
user experiencedata protectionrandom number generatorepic graphicsonline casinoslot gamemultiplierstransaction methodslow minimum depositrng systemsensational winseasy transactionse-walletsmedical equipment manufacturingpc compatiblemobile access
Built with from their website
ShareThisFlexSliderjQueryFlickityGoogle AnalyticsAmazon AWSGoogle Hosted Libraries
Add your raise, your deck and your story, and put GlySure Ltd in front of investors. Or tell us what we have wrong.